Early Access

10-KPeriod: FY2019

CVS HEALTH Corp Annual Report, Year Ended Dec 31, 2019

Filed February 18, 2020For Securities:CVS

Summary

CVS Health Corporation's (CVS) 2019 10-K filing highlights a year of significant transformation, largely driven by the transformative acquisition of Aetna completed in late 2018. This integration propelled the company's revenue growth by 32.0% to $256.8 billion, fueled by the newly added Health Care Benefits segment which encompasses Aetna's insurance operations. The company continues to focus on its strategy of being a consumer-centric health innovator, aiming to make healthcare more affordable, accessible, simple, and seamless. Financially, the company navigated substantial debt from the Aetna acquisition, reporting total revenues of $256.8 billion for 2019. Operating income saw a significant increase to $11.99 billion, primarily due to the absence of large goodwill impairment charges from the prior year and the impact of the Aetna integration. The company remains committed to its multi-faceted business model encompassing Pharmacy Services, Retail/LTC, and Health Care Benefits, while diligently managing integration costs and debt levels.

Financial Statements
Beta
Revenue$256.78B
Cost of Revenue$158.72B
Gross Profit$98.06B
Operating Expenses$244.79B
Operating Income$11.99B
Interest Expense$3.04B
Net Income$6.63B
EPS (Basic)$5.10
EPS (Diluted)$5.08
Shares Outstanding (Basic)1.30B
Shares Outstanding (Diluted)1.30B

Key Highlights

  • 1Total revenues surged by 32.0% to $256.8 billion in 2019, largely driven by the inclusion of Aetna's operations.
  • 2Operating income increased substantially to $11.99 billion in 2019, up from $4.02 billion in 2018, benefiting from the absence of prior year goodwill impairment charges and the Aetna acquisition.
  • 3The company is actively managing its significant debt load incurred from the Aetna acquisition, which totaled $64.7 billion in long-term debt at the end of 2019.
  • 4The Pharmacy Services segment demonstrated growth, with total revenues increasing by 5.0% to $141.5 billion, supported by increased claims volume and improved purchasing economics.
  • 5The Retail/LTC segment reported a 3.1% revenue increase to $86.6 billion, driven by pharmacy revenue growth and same-store sales, though operating income was impacted by store rationalization charges and the sale of a subsidiary.
  • 6The Health Care Benefits segment, significantly expanded by the Aetna acquisition, saw total revenues jump by 676.7% to $69.6 billion.
  • 7CVS Health is continuing its strategic focus on integrating its pharmacy, retail, and health insurance businesses to create a more comprehensive and consumer-centric healthcare experience.

Frequently Asked Questions